Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Contact
About us
Links
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
Market Strategy
Articles
News
Daily Comment
Visie Van De Week
Real-time charts
About us
Contact
Links
About us
Contact
Links
Accordion Title
Accordion Content
more items +
After months of box-office busts, Hollywood roars back with ‘Zootopia 2’
How Amazon’s stock could soar 30% thanks to its cloud business
I’m dating a guy with $80K in student-loan debt. Is this a red flag?
Are Oracle bears too pessimistic? This analyst thinks the stock can rise 90%.
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
Elon Musk offers two non-Tesla stock picks to play the future of AI
Trump says he’s made his decision on the next Fed chair. Here’s what to know about front-runner Kevin Hassett.
Here’s what might turn the tide for value stocks and the broader market over growth stocks in 2026
Manufacturers shrink for 9th month in a row, ISM finds. Tariffs hurt sales and keep lid on hiring.
Alphabet and Nvidia alone make up a third of the S&P 500’s gains this year, in a sign of Big Tech’s dominance
Why Meta’s stock may be ready to rally 70%, despite Zuckerberg’s massive AI-spending plans
Synopsys’ stock gets an Nvidia boost. Here’s what to know.
After months of box-office busts, Hollywood roars back with ‘Zootopia 2’
How Amazon’s stock could soar 30% thanks to its cloud business
I’m dating a guy with $80K in student-loan debt. Is this a red flag?
Are Oracle bears too pessimistic? This analyst thinks the stock can rise 90%.
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
Elon Musk offers two non-Tesla stock picks to play the future of AI
Trump says he’s made his decision on the next Fed chair. Here’s what to know about front-runner Kevin Hassett.
Here’s what might turn the tide for value stocks and the broader market over growth stocks in 2026
Manufacturers shrink for 9th month in a row, ISM finds. Tariffs hurt sales and keep lid on hiring.
Alphabet and Nvidia alone make up a third of the S&P 500’s gains this year, in a sign of Big Tech’s dominance
Why Meta’s stock may be ready to rally 70%, despite Zuckerberg’s massive AI-spending plans
Synopsys’ stock gets an Nvidia boost. Here’s what to know.
Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men
1-12-25
Memo also reportedly mentions vaccines for flu and pneumonia.
Share this on:
